SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

20 May 2023 Evaluate
A slight decline in the revenue of Rs. 509.70 millions was seen for the March 2023 quarter as against Rs. 523.10 millions during year-ago period.The Total revenue for the quarter ended March 2023 of  Rs. 92.90  millions  grew by 128.82% from Rs. 40.60 millions.Operating profit for the quarter ended March 2023 rose to 135.50 millions as compared to 66.80 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 509.70 523.10 -2.56 2179.80 2120.10 2.82 2179.80 2120.10 2.82
Other Income 69.60 21.40 225.23 188.40 77.80 142.16 188.40 77.80 142.16
PBIDT 135.50 66.80 102.84 402.10 360.00 11.69 402.10 360.00 11.69
Interest 8.00 3.10 158.06 21.90 9.70 125.77 21.90 9.70 125.77
PBDT 127.50 63.70 100.16 380.20 350.30 8.54 380.20 350.30 8.54
Depreciation 14.30 15.60 -8.33 58.50 66.60 -12.16 58.50 66.60 -12.16
PBT 113.20 48.10 135.34 321.70 283.70 13.39 321.70 283.70 13.39
TAX 20.30 7.50 170.67 78.30 70.70 10.75 78.30 70.70 10.75
Deferred Tax -7.30 -7.70 -5.19 -5.70 -9.40 -39.36 -5.70 -9.40 -39.36
PAT 92.90 40.60 128.82 243.40 213.00 14.27 243.40 213.00 14.27
Equity 57.70 57.70 0.00 57.70 57.70 0.00 57.70 57.70 0.00
PBIDTM(%) 26.58 12.77 108.18 18.45 16.98 8.64 18.45 16.98 8.64

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×